Congratulations to Wesley Legant for being selected as a recipient of one of the National Institutes of Health 93 awards to fund highly innovative, high-impact biomedical research as part of its High-Risk, High-Reward Research Program!

Wesley Legant, PhD, assistant professor in the departments of pharmacology and biomedical engineering, was selected as one of NIH Director’s New Innovator Award recipients this week. Legant will receive $2.2 million to support innovative biomedical research.

Legant, a member of the UNC Lineberger Comprehensive Cancer Center, will develop cutting edge microscopy and microfluidic devices and techniques to monitor single molecule dynamics over time in differentiating cells. His lab’s research could establish a foundation of knowledge for how gene expression is regulated in both normal and disease settings. Earlier this year, Legant was honored as a Searle Scholar and a Beckman Young Investigator.

The National Institutes of Health awarded 93 grants totaling approximately $267 million over the next five years through its High-Risk, High-Reward Research Program to fund highly innovative and unusually impactful biomedical or behavioral research proposed by extraordinarily creative scientists.

~Read the full article by Mark Derewizc in UNC School of Medicine News.